natgillin/translations-raw huggingface dataset:
Spectrila is indicated as a component of antineoplastic combination therapy for the treatment of acute lymphoblastic leukaemia (ALL) in paediatric patients from birth to 18 years and adults.
Zdravilo Spectrila je indicirano kot sestavni del kombinirane terapije z delovanjem na novotvorbe za zdravljenje akutne limfoblastne levkemije (ALL) pri pediatričnih bolnikih od rojstva do starosti 18 let in odraslih.
Spectrila is provided as a powder for concentrate for solution for infusion.
Zdravilo Spectrila je na voljo kot prašek za koncentrat za raztopino za infundiranje.
Spedra is not indicated for use in women.
Zdravilo Spedra ni indicirano za uporabo pri ženskah.
Speech disorder
Bolezni živčevja
Speed of administration
Hitrost injiciranja
Speke Operations, Fleming Road, Liverpool,
Speke Operations Fleming Road Liverpool
Spenomegaly Splenic rupture
rpastocelična krizaa splenomegalija a
Sperm results were available for the majority of patients: 63% of the trial population, corresponding to 31 patients of the 49 patients included, for whom follow-up sperm results after 6 months of hydroxycarbamide treatment were available.
Rezultati glede sperme so bili na voljo za večino bolnikov: 63 % populacije v preskušanju, kar ustreza 31 bolnikov od 49 vključenih bolnikov, za katere so bili na voljo rezultati glede sperme iz spremljanja po 6-mesečnem zdravljenju s hidroksikarbamidom.
sPGA “clear” or “minimal”, n (%)
sPGA “čisto” ali “minimalno”, n (%)
Sphincter of Oddi Spasm
Spazem Oddijevega sfinktra
Spike (under protective paper)
konica zaščitni (pod zaščitnim papirjem) papir
Spike Protective (under protective paper) paper
konica zaščitni (pod zaščitnim papirjem) papir
Spillages must be wiped immediately.
Razlito suspenzijo nemudoma obrišite.
Spin transfer from porfimer sodium to molecular oxygen may then generate singlet oxygen.
Sučni prenos od PhotoBarra do molekulskega kisika lahko nato proizvede kisik singlet.
Spinal and/or epidural anaesthesia
Spinalna in/ali epiduralna anestezija
Spinal cord compression
Kompresija hrbtenjače
Spinal mobility
Gibljivost hrbtenice
Spinal mobility was assessed by BASMI at Baseline, Week 12 and Week 24.
Spinalna mobilnost je bila ocenjena z BASMI na začetku zdravljenja, 12. teden in 24. teden.
Spinal or cervical cord compression
Kompresija hrbtenice ali hrbtenjače
Spinal/Cervical cord compression
Kompresija hrbtenjače/vratne hrbtenice
Spinning sensation
občutek vrtenja,
Spinosad and milbemycin oxime have been shown to be substrates for P-glycoprotein (P-gp) and therefore could interact with other P-gp substrates (for example, digoxin, doxorubicin) or other macrocyclic lactones.
Dokazano je, da sta spinosad in milbemicin oksim substrata za P-glikoprotein (P-gp), zato lahko medsebojno delujeta z drugimi P-gp-substrati (npr. digoksinom in doksorubicinom) ali drugimi makrocikličnimi laktoni.
Spironolactone Ceva 10 mg : Brown bisected oval tablet of 10 mm length.
Spironolactone Ceva 10 mg: Rjava, na pol deljiva ovalna tableta dolžine 10 mm.
Spironolactone Ceva 10 mg: White, with a slight brownish mottling, bisected oval tablet of 10 mm length.
Spironolactone Ceva 10 mg: Bela, z rjavkasto prevleko, na pol deljiva ovalna tableta dolžine 10 mm.
Spironolactone Ceva 40 mg: White, with a slight brownish mottling, oval tablet of 17 mm length with three parallel break-lines.
Spironolactone Ceva 40 mg: Bela, z rjavkasto prevleko, ovalna tableta dolžine 17 mm s tremi paralelnimi zarezami.
Spironolactone is rapidly and completely metabolised by the liver into its active metabolites, 7α- thiomethyl-spironolactone and canrenone, which are the primary metabolites in the dog.
Spironolakton se hitro in v celoti metabolizira v jetrih v aktivna metabolita, 7-α-tiometil-spironolakton in kanrenon, ki sta primarna metabolita pri psih.
Spironolactone is rapidly and completely metabolised by the liver into its active metabolites, 7α- thiomethyl-spironolactone and canrenone, which are the primary metabolites in the dog.
Spironolakton se hitro in v celoti metabolizira v jetrih v aktivna metabolita, 7α-tiometil-spironolakton in kanrenon, ki sta primarna metabolita pri psih.
Spleen
0,005
Spleen
Vranica
Spleen disorder
obolenje vranice
Spleen size should be evaluated regularly.
Velikost vranice je treba ugotavljati redno.
Spleen volume
Prostornina vranice
Spleen Volume (MN)
Prostornina vranice (MN)
Spleen1
vranica1
Splenic adverse reactions
Neželeni učinki, povezani z vranico
Splenic infarction
infarkt vranice
Splenic rupture a
raztrganje vranicea
Splenic rupture Sickle cell crisisa
raztrganje vranice srpastocelična
Splenic rupture Sickle cell crisisa
raztrganje vranice srpastocelična krizaa
Splenic rupturea
raztrganje vranicea
Splenic rupturea Sickle cell crisisa
ruptura vranicea srpastocelična krizaa
Splenic rupturea Splenomegalya, e Sickle cell crisisa
spleno- megalijaa, e srpastocelična krizaa
Splenic rupturea Thrombocytopeniaa
raztrganje vranicea trom- bocitopenijaa
Splenic rupturea Thrombocytopeniaa
rupture vranicea trombocitopenijaa
Splenomegaly Anaemia
splenomegalija anemija
Splenomegaly and splenic rupture were also reported.
Poročali so tudi o splenomegaliji in raztrganju vranice.
Splenomegaly and splenic rupture were also reported.
Poročali so tudi o splenomegaliji in rupturi vranice.
Splenomegaly is a direct effect of treatment with filgrastim.
Splenomegalija je neposredna posledica zdravljenja s filgrastimom.
Splenomegaly was reported to be related to filgrastim therapy in < 3% of patients.
Poročali so tudi, da je bila splenomegalija povezana z zdravljenjem s filgrastimom pri < 3 % bolnikov.
Splenomegaly was reported to be related to filgrastim therapy in < 3% of patients.
Poročali so, da je splenomegalija pri < 3 % bolnikov povezana z zdravljenjem s filgrastimom.
Splenomegaly was reported to be related to filgrastim therapy in <3% of patients.
Poročali so, da je splenomegalija pri < 3 % bolnikov povezana z zdravljenjem s filgrastimom.
Splenomegaly was reported to be related to filgrastim therapy in <3% of patients.
Poročali so, da je splenomegalija pri < 3% bolnikov povezana z zdravljenjem s filgrastimom.
Splenomegalya
plenomegalija
Splenomegalya Anaemia
plenomegalijaa anemija
Splenomegalya, e
raztrganje vranicea
Split influenza virus inactivated, containing antigen equivalent to:
razcepljen virus influence, inaktiviran, ki vsebuje antigene, ki ustrezajo:
Split influenza virus inactivated, containing antigen* equivalent to:
razcepljen virus influence, inaktiviran, ki vsebuje antigene*, ki ustrezajo:
Split influenza virus inactivated, containing antigen* equivalent to: A/California/7/2009 (H1N1)v like strain (X-179A) 3.75 micrograms**
sevu A/California/7/2009 (X-179A) podobnemu sevu A/California/7/2009 (H1N1)v 3,75 mikrogramov
Split influenza virus inactivated, containing antigen* equivalent to: A/Indonesia/05/2005 (H5N1) 3.75 micrograms**
inaktivirane delce virusa gripe, ki vsebujejo antigene*, ki ustrezajo: A/Indonesia/05/2005 (H5N1) 3,75 mikrogramov
Split influenza virus, inactivated, containing antigen equivalent to:
razcepljen virus influence, inaktiviran, ki vsebuje antigene, ki ustrezajo:
Split influenza virus, inactivated, containing antigen* equivalent to
razcepljen virus influence, inaktiviran, ki vsebuje antigene*, ki ustrezajo
Split influenza virus, inactivated, containing antigen* equivalent to:
inaktivirane delce virusa gripe, ki vsebujejo antigene*, ki ustrezajo:
Split influenza virus, inactivated, containing antigen* equivalent to:
inaktivirani delci virusa gripe, ki vsebujejo antigene*, ki ustrezajo
Split influenza virus, inactivated, containing antigen* equivalent to:
razcepljen virus influence, inaktiviran, ki vsebuje antigene*, ki ustrezajo
Split Influenza virus, inactivated, containing antigen* equivalent to:
Razgrajen virus gripe*, inaktiviran, vsebuje antigene, ki ustrezajo naslednjim sevom:
Split your dose into two injections:
Odmerek razdelite na dve injiciranji:
Split-thickness skin graft donor site wound studies (pooled)
Študiji na ranah na mestu odvzema presadka delne debeline kože (zbirno)
spondyloarthropathy, Sjogren’s syndrome, arthritis, myopathy
spondiloartropatija, Sjogrenov sindrom, artritis, miopatija
Sponge your child’s skin with cool (not cold) water
otrokovo kožo hladite s hladno (ne mrzlo) vodo,
Sponge:
Goba
Sponge:
Goba:
Spontaneous abortion
pontani splav,
Spontaneous abortion (rate of 45-49%) and congenital malformations (estimated rate of 23-27%) have been reported following MMF exposure during pregnancy.
Po izpostavljenosti mofetilmikofenolatu med nosečnostjo so poročali o spontanem splavu (ocenjeni delež 45 – 49 %) in kongenitalnih malformacijah (ocenjeni delež 23 – 27 %).
Spontaneous abortion (rate of 45-49%) and congenital malformations (estimated rate of 23-27%) have been reported following MMF exposure during pregnancy.
Po izpostavljenosti mofetilmikofenolatu med nosečnostjo so poročali o spontanem splavu (ocenjeni delež 45–49 %) in kongenitalnih malformacijah (ocenjeni delež 23–27 %).
Spontaneous abortions have been reported in 45 to 49% of pregnant women exposed to mycophenolate mofetil, compared to a reported rate of between 12 and 33% in solid organ transplant patients treated with immunosuppressants other than mycophenolate mofetil.
Pri nosečnicah, izpostavljenih mofetilmikofenolatu, so poročali o spontanih splavih pri 45 do 49 % bolnic v primerjavi z med 12 in 33 % pri bolnicah s presajenim solidnim organom, zdravljenih z drugimi imunosupresivi razen mofetilmikofenolata.
Spontaneous bleeding from the eye, rectum, gums or in the abdomen around the internal organs
Spontana krvavitev iz očesa, danke, dlesni ali v trebuh okrog notranjih organov
Spontaneous bleeding or bruising (signs of low level of platelets, also known as thrombocytopenia)
pontane krvavitve ali pojavljanje modric (znaki zmanjšanega števila trombocitov, kar imenujemo tudi trombocitopenija)
Spontaneous bleeding or bruising, signs of low level of platelets (thrombocytopenia)
pontana krvavitev ali pojav podplutb sta znaka nizke ravni krvnih ploščic (trombocitopenija)
Spontaneous cases of serious liver injuries, increased liver enzymes, hyperbilirubinaemia have been reported during the post marketing phase (see section 4.4).
V obdobju po začetku trženja so poročali o primerih resnih okvar jeter, povišanih jetrnih encimih in hiperbilirubinemiji (glejte poglavje 4.4).
Spontaneous exacerbations in chronic hepatitis B are relatively common and are characterised by transient increases in serum ALT.
Spontana poslabšanja kroničnega hepatitisa B so razmeroma pogosta; značilna zanje so prehodna zvišanja serumske ALT.
Spontaneous penile erection
spontana erekcija penisa
Spontaneous penile erection, Menstrual disorder
spontane erekcije penisa, menstrualne motnje
Spontaneous serious adverse reactions of liver injury have been reported during the post marketing phase.
V obdobju po začetku trženja so poročali o spontanih hudih neželenih reakcijah zaradi okvare jeter.
Spoon for stirring
žličko za mešanje
Sporadic and mild ALT (alanine aminotransferase) elevations up to 4 times the upper reference range and not associated with histopathological liver lesions or noticeable changes in other liver parameters may be observed in some dogs during the course of treatment.
Pri nekaterih psih se lahko med zdravljenjem opazi sporadično in blago zvišanje vrednosti ALT (alanin aminotransferaze) do 4 kratne referenčne vrednosti, ki pa ni povezano s histopatološkimi spremembami v jetrih ali drugimi opaznimi spremembami v vrednosti jetrnih parametrov.
Spot-on
Kožni nanos
Spot-on
Kožni nanos.
Spot-on application only.
Samo za kožni nanos.
Spot-on application only.
Samo za zunanjo uporabo (spot-on nanos).
Spot-on applicator
Nalepka na aplikatoju za kožni nanos
Spot-on applicator (COC) with polymer cap
Aplikator za kožni nanos (COP) s polimernim pokrovčkom
Spot-on applicator (PE/Alu/PE)
Aplikator za kožni nanos (PE/Alu/PE)
Spot-on applicator label
Nalepka na kapalki za kožni nanos
Spot-on applicator made of a multilayered complex of aluminium and polyethylene (PE) with a head made of HDPE, top-sealed with a liner complex (aluminium/polyester/sealable PE layer).
Aplikator vsebuje večslojni kompleks aluminija in polietilena (PE) z glavo narejeno iz HDPE, vrh je zatesnjen z linearnim kompleksom (aluminij/poliester/zatesnitveni PE sloj).
Spot-on applicator made of a multilayered complex of aluminium and polyethylene (PE) with HDPE, top-sealed with a liner complex (aluminium/polyester/sealable PE layer).
Kapalka vsebuje multislojni kompleks aluminija in polietilena (PE) z HDPE, vrh je zatesnjen z linearnim kompleksom (aluminij/poliester/zatesnitveni PE sloj).
Spot-on solution
Kožne kapljice,
Spot-on solution
Kožne kapljice, raztopina
Spot-on solution
Kožni nanos
Spot-on solution
Kožni nanos, raztopina
Spot-on solution
Kožni nanos, raztopina.
Spot-on solution
Raztopina za kožni nanos
Spot-on solution
Raztopina za kožni nanos.
Spot-on solution
Raztopina za kožni poliv
Spot-on solution for external application to the skin
Kožni nanos, raztopina za zunanjo uporabo na koži.
Spot-on solution Intervet UK Limited Walton Manor, Walton, Milton Keynes,
Kožni nanos, raztopina Intervet UK Limited Walton Manor, Walton, Milton Keynes,
Spot-on solution.
Kožni nanos, raztopina
Spot-on solution.
Kožni nanos, raztopina.
Spot-on solution.
Raztopina za kožni nanos.
Spot-on use
Kožni nanos
Spot-on use
Kožni nanos.
Spot-on use
Kožni poliv
Spot-on use
Nanos na
Spot-on use
nanos na kožo
Spot-on use
Nanos na kožo.
Spot-on use
Nanos na zatilje
Spot-on use for external application to the skin
Za zunanjo uporabo na koži.
Spot-on use for external application.
Za zunanjo uporabo na koži.
Spot-on use.
Kožni nanos
Spot-on use.
Kožni nanos.
Spot-on use.
Nanos na kožo.
Spot-on-solution
kožni nanos, raztopina
Spot-on-solution.
Kožni nanos, raztopina.
Spray application
Nanašanje s pršenjem
Spray application of Raplixa should only be done using the provided spray application accessories and the pressure should not exceed 1.5 bars (22 psi).
Nanos zdravila Raplixa s pršilom je dovoljen le s priloženimi pripomočki za pršilo, tlak pa ne sme preseči 1,5 bara (22 psi).
Spray application using Raplixa spray device followed by gelatin sponge
Nanos s pršilom z uporabo pripomočka RaplixaSpray, ki mu sledi uporaba želatinske gobice
Spray application:
Pršenje:
spray bottle:
Steklenica z 2 vpihoma:
Spray distance from tissue and CO2 pressure should be within the ranges recommended by the manufacturer (see table in Section 6.6 for pressure and distance).
Razdalja med pršilnikom in tkivom ter tlak CO2 morata biti v razponih, ki jih priporoča izdelovalec (za tlak in razdaljo glejte tabelo v poglavju 6.6) .
Spray distance from tissue and pressure should be within the ranges recommended by the manufacturer (see table in Section Instructions for Use).
Razdalja med pršilnikom in tkivom ter tlak morata biti v razponu, ki ga priporoča izdelovalec (glejte tabelo v poglavju Navodila za uporabo).
Spray dried pork liver
prašičja jetra (pripravljena z razprševalnim sušenjem)
Spray method
Razprševanje
Spray method
Razprševanje:
Spray preferably in a well ventilated area.
Razpršilo po možnosti uporabljajte v dobro prezračenem prostoru.
Spray RevitaCAM into dog’s mouth
Zdravilo RevitaCAM razpršite v gobec psa
Spray set to be used
Komplet pršila, ki se uporabi
Spray set to be used
Uporabljeni pršilni komplet
Spray vaccination or in drinking water use.
Pršenje ali dajanje v vodo za pitje.
Spray vaccination:
Cepljenje z razprševanjem:
sprayer (alu)
vsebnik s pršilom (alu)
sprayer (glass/PE)
pršilnik (steklo/PE)
Spread of IMLYGIC to close contacts or healthcare providers after direct contact with injected lesions or body fluids
Prenos zdravila IMLYGIC na osebe, ki so v tesnem stiku z bolnikom, ali zdravstvene delavce po neposrednem stiku s spremembo, v katero je bilo injicirano zdravilo, in telesnim tekočinam zdravljenega bolnika.
Sprimeo 150 mg film-coated tablets Aliskiren
Sprimeo 150 mg filmsko obložene tablete aliskiren
Sprimeo 300 mg film-coated tablets Aliskiren
Sprimeo 300 mg filmsko obložene tablete aliskiren
Sprimeo HCT 150 mg/12.5 mg film-coated tablets are white, oval film-coated tablets imprinted with “LCI” on one side and “NVR” on the other.
Filmsko obložene tablete Sprimeo HCT 150 mg/12,5 mg so bele ovalne filmsko obložene tablete z oznako “LCI” na eni strani in “NVR” na drugi.
Sprimeo HCT contains lactose (milk sugar).
Zdravilo Sprimeo HCT vsebuje laktozo (mlečni sladkor).
Sprimeo HCT in combination with an ‘angiotensin converting enzyme (ACE) inhibitors’ or ‘angiotensin receptor blockers’ (ARBs) must not be used in patients with diabetes, or moderate or severe kidney impairment.
Zdravilo Sprimeo HCT se v kombinaciji z zaviralcem angiotenzinske konvertaze ali zaviralcem angiotenzinskih receptorjev ne sme uporabljati pri bolnikih s sladkorno boleznijo oziroma zmerno ali hudo okvaro ledvic.
Sprimeo HCT is contraindicated in patients with hypercalcaemia and should only be used after correction of any pre- existing hypercalcaemia.
Zdravilo Sprimeo HCT je kontraindicirano pri bolnikih s hiperkalciemijo in ga je mogoče uporabljati šele po korekciji morebitne že prisotne hiperkalciemije.
Sprimeo HCT is contraindicated in patients with severe renal impairment or anuria (see section 4.3).
SprimeoSprimeoPri bolnikih s hudo okvaro ledvic in pri bolnikih z anurijo je uporaba zdravila Sprimeo HCT kontraindicirana (glejte poglavje 4.3).
Sprimeo HCT is not recommended during pregnancy, and must not be taken when more than 3 months pregnant, as it may cause serious harm to your baby if used after the third month of pregnancy.
3 mesece, ga ne smete jemati, ker lahko uporaba po tretjem mesecu nosečnosti povzroči resno škodo vašemu otroku.
Sprimeo may be taken alone or in combination with other medicines for hypertension, with the exception of ‘angiotensin converting enzyme (ACE) inhibitors’ or ‘angiotensin receptor blockers’ (ARBs) in patients with diabetes, or moderate or severe kidney impairment.
Zdravilo Sprimeo se lahko jemlje samostojno ali v kombinaciji z drugimi zdravili za zdravljenje hipertenzije z izjemo „zaviralcev angiotenzinske konvertaze (ACE)“ ali „zaviralcev angiotenzinskih receptorjev (ARB)“ pri bolnikih s sladkorno boleznijo oziroma zmerno ali hudo okvaro ledvic.
Sprimeo may be used alone or in combination with other antihypertensive agents with the exception of use in combination with angiotensin converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) in patients with diabetes mellitus or renal impairment (glomerular filtration rate (GFR) < 60 ml/min/1.73 m2) (see sections 4.3, 4.4 and 5.1).
Zdravilo Sprimeo se lahko jemlje samostojno ali v kombinaciji z drugimi učinkovinami za zniževanje krvnega tlaka, razen v kombinaciji z zaviralci encima angiotenzinske konvertaze (zaviralci ACE) ali zaviralci angiotenzinskih receptorjev II pri bolnikih s sladkorno boleznijo ali okvaro ledvic (s hitrostjo glomerulne filtracije (GFR) < 60 ml/min/1,73 m2) (glejte poglavja 4.3, 4.4 in 5.1).
Sprinkle the contents of the capsule on the food (illustration d).
Posujte vsebino kapsule po hrani (slika d).
Sprinkle the granules onto apple sauce or yogurt.
Stresite zrnca v jabolčno čežano ali jogurt.
Sprinkling in orange juice or any acidic fruit juice
Stresanje v pomarančni sok ali kateri koli kisel sadni sok
SPRYCEL 100 mg film-coated tablets dasatinib
SPRYCEL 100 mg filmsko obložene tablete dasatinib
SPRYCEL 140 mg film-coated tablets dasatinib
SPRYCEL 140 mg filmsko obložene tablete dasatinib
SPRYCEL 20 mg film-coated tablets EU/1/06/363/004
SPRYCEL 20 mg filmsko obložene tablete EU/1/06/363/004
SPRYCEL 20 mg, 50 mg or 70 mg film-coated tablets are available in cartons containing
Zdravilo SPRYCEL 20 mg, 50 mg ali 70 mg filmsko obložene tablete je na voljo v škatlah s
SPRYCEL 20 mg, 50 mg, 70 mg film-coated tablets
SPRYCEL 20 mg, 50 mg, 70 mg filmsko obložene tablete
SPRYCEL 20 mg: the film-coated tablet is white to off-white, biconvex, round with “BMS” debossed on one side and “527” on the other side.
SPRYCEL 20 mg: bele do sivobele, bikonveksne in okrogle filmsko obložene tablete z oznako “BMS” na eni in “527” na drugi strani.
SPRYCEL 80 mg film-coated tablets dasatinib
SPRYCEL 80 mg filmsko obložene tablete dasatinib
SPRYCEL 80 mg, 100 mg, 140 mg film-coated tablets Alu/Alu blisters (perforated unit dose blisters).
SPRYCEL 80 mg, 100 mg, 140 mg filmsko obložene tablete Alu/Alu pretisni omoti (perforirani enoodmerni pretisni omoti).
SPRYCEL imatinib
Zdravilo imatinib
Sprycel is a medicine that contains the active substance dasatinib.
Sprycel je zdravilo, ki vsebuje zdravilno učinkovino dasatinib.
SPRYCEL is also used to treat Philadelphia chromosome positive (Ph+) acute lymphoblastic leukaemia (ALL), and lymphoid blast CML in adults who are not benefiting from prior therapies.
Zdravilo SPRYCEL uporabljamo tudi za zdravljenje akutne limfoblastne levkemije (ALL) s prisotnostjo kromosoma Philadelphia (Ph+) in KML v obdobju limfoblastne preobrazbe pri odraslih, pri katerih so bila predhodna zdravljenja neuspešna.
Sprycel is an anticancer medicine.
Zdravilo Sprycel je zdravilo proti raku.
SPRYCEL is not recommended for patients below 18 years of age.
Uporaba zdravila SPRYCEL pri bolnikih, mlajših od 18 let, ni priporočljiva.
SPRYCEL is prescribed for adults.
Zdravilo SPRYCEL je namenjeno le odraslim bolnikom.
Sprycel is taken once a day, consistently either in the morning or in the evening.
Zdravilo Sprycel se jemlje enkrat dnevno, bodisi vedno zjutraj ali vedno zvečer.
Sprycel is used when patients cannot tolerate, or when their disease is not responding to, other treatments.
Zdravilo Sprycel se uporablja pri bolnikih, ki ne morejo prenašati drugih načinov zdravljenja ali pa se nanje ne odzivajo.
SPRYCEL n= 259
Zdravilo SPRYCEL n = 259
Sprycel tablets must be swallowed whole.
Bolnik mora tablete pogoltniti cele.
SPRYCEL with food and drink
Zdravilo SPRYCEL skupaj s hrano in pijačo
Sputum discoloured
obarvan izmeček
Sputum discoloured Bronchitis Bronchopneumonia Lung infection Pharyngitis
kongestija dihal obarvan sputum bronhitis bronhopnevmonija okužba pljuč faringitis
Sputum infection
okužba sputuma,
Sputum PK exposure in children aged 7 to 16 years old was approximately one-third of adult exposure.
FK izpostavljenost v sputumu pri otrocih, starih 7 do 16 let, je znašala približno eno tretjino izpostavljenosti odraslih.
Squalane
Skvalan
Squalene 9.75 milligrams
kvalen 9,75 miligramov
Squamous cell (N=473)
Adenokarcinom Karcinom velikih celic
squamous cell carcinoma
ploščatocelič ni karcinom
Squamous cell carcinoma (SCC) was reported in 1.3% (2/160) of patients treated with Imiquimod, in 0.6% (1/159) treated with vehicle.
O karcinomu skvamoznih celic so poročali pri 1,3 % (2/160) bolnikov, zdravljenih z imikvimodom, ter pri 0,6 % (1/159) bolnikov, zdravljenih z vehiklom.
Squamous cell carcinoma of skin
ploščatocelični karcinom kože
squamous cell carcinoma of skin, basal cell carcinoma, skin papilloma
ploščatocelični karcinom kože, bazalnocelični karcinom, kožni papilom
Squamous cell carcinoma of the skin (SCC) has been reported in patients , some of whom have reported prior phototoxic reactions.
Pri bolnikih, med katerimi so nekateri v preteklosti poročali o fototoksičnih reakcijah, so poročali o ploščatoceličnemu karcinomu kože.
Squamous cell carcinoma of the skin (SCC) has been reported in patients, some of whom have reported prior phototoxic reactions.
pri bolnikih, med katerimi so nekateri v preteklosti poročali o fototoksičnih reakcijah, so poročali o ploščatoceličnemu karcinomu kože.
squamous cell carcinoma*
ploščatocelič ni karcinom
Squeezable tube (polyethylene)
Stisljiva tuba (polietilen)
Squeeze all of the contents of one ampoule into the medicine reservoir of the Zirela Nebuliser Handset (Figure 1).
Vso vsebino ene ampule iztisnite v vsebnik za zdravilo nebulatorja Zirela (slika 1).
Squeeze from the bottom of the sachet toward the open end.
Iztisnite od dna vrečice proti odrtem koncu.
Squeeze out the contents completely into the vial (Figure 1d).
Celotno vsebino stisnite v vialo (slika 1d).
Squeeze pipette firmly applying the entire contents directly to the skin.
Merilno kapalko močno stisnite in nanesite vso vsebino neposredni na kožo.